Searching for Biomarkers in the Blood of Patients at Risk of Developing Parkinson’s Disease at the Prodromal Stage

Parkinson’s disease (PD) is diagnosed many years after its onset, under a significant degradation of the nigrostriatal dopaminergic system, responsible for the regulation of motor function. This explains the low effectiveness of the treatment of patients. Therefore, one of the highest priorities in...

Descripción completa

Detalles Bibliográficos
Autores principales: Katunina, Elena A., Blokhin, Victor, Nodel, Marina R., Pavlova, Ekaterina N., Kalinkin, Alexander L., Kucheryanu, Valerian G., Alekperova, Leyla, Selikhova, Marianna V., Martynov, Mikhail Yu., Ugrumov, Michael V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915927/
https://www.ncbi.nlm.nih.gov/pubmed/36768161
http://dx.doi.org/10.3390/ijms24031842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915927/
https://www.ncbi.nlm.nih.gov/pubmed/36768161
http://dx.doi.org/10.3390/ijms24031842

Ejemplares similares